Doug Mack

Title: Doug Mack - Innovator in Antimicrobial Research

Introduction

Doug Mack is a notable inventor based in Riverside, IL (US). He has made significant contributions to the field of antimicrobial agents, diagnostic reagents, and vaccines. His work focuses on unique components derived from Apicomplexan parasites, which are crucial for developing innovative therapeutic solutions.

Latest Patents

Doug Mack holds a patent for "Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components." This invention relates to the uses of chorismate synthase, a component of plant-like metabolic pathways that are not generally operative in animals. The patent outlines methods to develop compositions that interfere with Apicomplexan growth and survival. The components of these pathways include enzymes, transit peptides, and nucleotide sequences that encode these enzymes and peptides. The invention also discusses the development of diagnostic and therapeutic reagents and vaccines based on chorismate synthase and its inhibitors. He has 1 patent to his name.

Career Highlights

Doug Mack is associated with Apicomplexan Therapeutics, LLC, where he continues to advance his research and innovations. His work is pivotal in the ongoing fight against diseases caused by Apicomplexan parasites.

Collaborations

Some of his notable coworkers include Rima McLeod and Craig Roberts, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Doug Mack's innovative work in antimicrobial research highlights the importance of developing new therapeutic agents against Apicomplexan parasites. His contributions are vital for advancing medical science and improving health outcomes.